Why Hims & Hers Stock Slipped Today

Key Points

• The company is replacing its COO.

• It disclosed this in a regulatory document.

• 10 stocks we like better than Hims & Hers Health ›

The market often gets worried when a company announces a major change in its C-suite. On news that it was doing just that, on Friday the stock of consumer healthcare company Hims & Hers (NYSE: HIMS) was whacked with a more than 9% sell-off by investors. This occurred on a relatively stable day for the broader market, as the benchmark S&P 500 (SNPINDEX: ^GSPC) basically traded flat.

Outgoing and incoming

After market close Thursday, Hims & Hers disclosed in a regulatory filing that COO Nader Kabbani had vacated his position. The company added that he did so in order to take up a new advisory role for the company, in which he will, in its words "provide ongoing strategic guidance." He will also, Hims & Hers said, specifically assist in its special global initiatives through next July.

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »

Image source: Getty Images.

Kabbani is being replaced by Mike Chi, who is the chief commercial officer at present. His ascension and Kabbani's shift will both be effective Nov. 2.

Chi has been at Hims & Hers since April 2021; previous to that, he served in a variety of executive positions in marketing and product management. Among other roles, he was chief marketing officer at digital wedding planning company Zola, and vice president of marketing and e-commerce for fashion brand Intermix.

Consistency wanted

Based on what Hims & Hers said about Chi in the disclosure, he seems like a safe pair of hands to take the COO wheel. But investors like consistency and longevity in the C-suites of their investments, and with the latest change, the company isn't demonstrating this at the moment.

Should you invest $1,000 in Hims & Hers Health right now?

Before you buy stock in Hims & Hers Health, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Hims & Hers Health wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $626,942!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,157,870!*

Now, it’s worth noting Stock Advisor’s total average return is 1,063% — a market-crushing outperformance compared to 191% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.

See the 10 stocks »

*Stock Advisor returns as of September 29, 2025

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Hims & Hers Health. The Motley Fool has a disclosure policy.